N/A
Completed N=339
Risk Factors for Rebleeding in Patients With Obscure Gastrointestinal Bleeding
Source: ClinicalTrials.gov NCT01821326 ↗Enrolled (actual)
339
Serious AEs
0.0%
Results posted
Jan 2017
Primary outcomePrimary: Rebleeding Rate — 97 participants
Summary
The investigators investigated the rebleeding rate the risk factors for rebleeding after long-term follow-up (≥12 months) in patients who underwent capsule endoscopy for obscure gastrointestinal bleeding.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Rebleeding Rate |
97 | — |
Eligibility Criteria
Inclusion Criteria
- Patients who underwent capsule endoscopy in Shanghai Renji Hospital(China) from June 2002 to January 2012 for obscure gastrointestinal bleeding
Exclusion Criteria
- patients who did not undergo a gastroscopy and colonoscopy performed before capsule endoscopy examination; and
- patients with follow-up examination for other know clinical diseases.
Data sourced from ClinicalTrials.gov (NCT01821326). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.